Researchers from Duke-NUS School of Medicine and the National Center for Infectious Diseases of Singapore (NCID) have found that those vaccinated with the Pfizer-BioNTech vaccine develop effective antibodies that can neutralize not only the SARS-CoV-2 virus, but also SARS-CoV-1, as well as. According to scientists, this proves the possibility of creating a universal vaccine, reports News Medical.

During the national multicenter study of immunization monitoring of vaccination, Singapore specialists analyzed the antibody spectrum developed after vaccination against COVID-19 in those who suffered SARS SARS pneumonia caused by the SARS-CoV-1 coronavirus in 2003. The results of their work were published in the New England Journal of Medicine.

The authors suggested that mRNA vaccines (such as Pfizer-BioNTech) may be effective against pathogens of the group, including those that circulate so far only among animals and can potentially pass to humans..

To test their hypothesis, the researchers recruited eight SARS survivors, ten COVID-19 patients, and ten healthy people and compared the immune response in all three groups before and after vaccination..

Prior to vaccination, SARS survivors were found to have neutralizing antibodies to SARS-CoV-1, but not SARS-CoV-2.

After receiving two doses of mRNA vaccine, all patients showed high levels of neutralizing antibodies against both coronaviruses..

Scientists emphasized that this is the first proven case of cross-neutralizing antibodies against various coronaviruses..

"

At the moment, scientists are conducting an experimental study to develop a third-generation vaccine against various coronaviruses..

Pfizer vaccine efficacy declines faster than AstraZeneca News from Telegram. Subscribe to our channel https: // t. me / korrespondentnet Author: 1.